6X45
SARS-CoV2 spike glycoprotein N-terminal heptad repeat domain + SARS-CoV2(QEYKKEKE)
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | NSLS-II BEAMLINE 17-ID-1 |
| Synchrotron site | NSLS-II |
| Beamline | 17-ID-1 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2020-05-06 |
| Detector | DECTRIS EIGER X 9M |
| Wavelength(s) | 0.920087 |
| Spacegroup name | P 21 21 2 |
| Unit cell lengths | 53.543, 54.458, 80.119 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 45.040 - 2.200 |
| R-factor | 0.2463 |
| Rwork | 0.243 |
| R-free | 0.27840 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 6lxt |
| RMSD bond length | 0.002 |
| RMSD bond angle | 0.365 |
| Data reduction software | XDS |
| Data scaling software | autoPROC (1.0.5) |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.17.1_3660) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 80.120 | 2.270 |
| High resolution limit [Å] | 2.200 | 2.200 |
| Rmeas | 0.096 | 1.705 |
| Rpim | 0.038 | 0.666 |
| Number of reflections | 12351 | 1047 |
| <I/σ(I)> | 9 | 1.2 |
| Completeness [%] | 99.5 | 99.2 |
| Redundancy | 6.5 | 6.3 |
| CC(1/2) | 0.999 | 0.475 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 7.8 | 293 | Peptide solution: Lyophilized TFA salt dissolved in 1% w/v beta-D-octylglucoside; HRN (4 mg/mL), HRC-QEYKKEKE (3 mg/mL) Well solution: 0.1 M Tris pH 7.8, 26% w/v PEG3350, 0.3 M MgCl2 Drop: 1 uL peptide solution, 1 uL well solution Reservoir: 150 uL in VDXm plate |






